SAW Instrument GmbH, a Bonn, Germany-based company that develops, manufactures and sells innovative analytical systems for the markets of the life sciences, has closed a €1m second round of financing.
Investors include existing backers KI Kapital, and HTGF and new shareholder KfW.
The company intends to use the funds to expand sales & marketing activities and extend its product portfolio. SAW Instruments plans to expand its market presence in Central Europe, start making its first steps into the U.S. market. In addition, the company will launch two new products (The sam5 pro and the samX) in the second and third quarter of 2011.
Led by Managing Directors Sabine Bois and Dr. Markus Perpeet, SAW Instruments currently sells its label free, biomolecular interaction analytical systems to leading research institutions in Germany and Switzerland.